Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial
维布瑞替尼治疗既往接受过治疗的星形细胞瘤（IDH突变型，4级）和胶质母细胞瘤（IDH野生型，伴PTPRZ1-MET融合基因）：一项多中心、III期随机、开放标签试验
期刊:Cancer Communications
影响因子:24.9
doi:10.34133/cancomm.0019
Bao, Zhaoshi; Xue, Yake; Liu, Yanhui; Li, Shouwei; Wang, Liang; Qu, Yan; Mou, Yonggao; Yu, Rutong; Wu, Jinsong; Yao, Yu; Shu, Kai; Hu, Guangyuan; Cai, Linbo; Li, Wenbin; Qiu, Xiaoguang; Li, Yunqian; Zhang, Lei; Qi, Songtao; Ji, Ying; Ma, Chunxiao; Ma, Wenbin; Li, Gang; Tao, Rongjie; Sun, Chongran; Chen, Ligang; Lv, Sheng-Qing; Liang, Peng; Pan, Hao; Peter, Woo Yat Ming; Danny, Chan Tat Ming; Mao, Qing; Wei, Xinting; Jiang, Tao
